← Back to Clinical Trials
Recruiting NCT06192316

NCT06192316 Human Laboratory Study of the Effects of Nicotine Product Claims on Appeal, Perceptions, and Use Behavior

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06192316
Status Recruiting
Phase —
Sponsor Ohio State University Comprehensive Cancer Center
Condition Behavior, Risk
Study Type INTERVENTIONAL
Enrollment 450 participants
Start Date 2024-03-01
Primary Completion 2028-09-14

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
3x3 between-subjects experimental exposure

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 450 participants in total. It began in 2024-03-01 with a primary completion date of 2028-09-14.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study evaluates knowledge, feelings and thoughts regarding nicotine products among young adults who are susceptible to but do not use tobacco/nicotine and adults who use tobacco/nicotine.

Eligibility Criteria

Inclusion Criteria: * Young adult susceptible non-users aged 18-24 who have never used ONPs and have never used but are susceptible to using either: * combustible tobacco only (cigarettes, cigars, waterpipe) * non-combustible tobacco only (ST, ECs, heated tobacco products) * or both combustible and non-combustible tobacco (i.e., dual susceptibility) * Adult tobacco users aged 18-65 who have never used ONPs OR have used ONPs \>3 months ago and 10 times or less in their lifetime. All adult tobacco users must also be: * exclusive combustible tobacco users * exclusive non-combustible tobacco users * dual users * For adult tobacco users, we will define current use as use of combustible and/or non-combustible tobacco every day or some days for 6 months or longer * Willing and able to complete an in-person lab visit. Exclusion Criteria: * Age \< 18 or \> 65 * Are not susceptible non-users or current tobacco users * Are unwilling or unable to complete and in person lab visit. * Have used ONPs within the past 3 months * Have used ONPs more than 10 times in their lifetime

Contact & Investigator

Central Contact

The Ohio State University Comprehensive Cancer Center

✉ OSUCCCClinicaltrials@osumc.edu

📞 800-293-5066

Principal Investigator

Darren Mays, MPH, PhD

PRINCIPAL INVESTIGATOR

Ohio State University Comprehensive Cancer Center

Frequently Asked Questions

Who can join the NCT06192316 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Behavior, Risk. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06192316 currently recruiting?

Yes, NCT06192316 is actively recruiting participants. Contact the research team at OSUCCCClinicaltrials@osumc.edu for enrollment information.

Where is the NCT06192316 trial being conducted?

This trial is being conducted at Columbus, United States.

Who is sponsoring the NCT06192316 clinical trial?

NCT06192316 is sponsored by Ohio State University Comprehensive Cancer Center. The principal investigator is Darren Mays, MPH, PhD at Ohio State University Comprehensive Cancer Center. The trial plans to enroll 450 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology